Neoplasm Staging
"Neoplasm Staging" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Methods which attempt to express in replicable terms the extent of the neoplasm in the patient.
Descriptor ID |
D009367
|
MeSH Number(s) |
E01.789.625
|
Concept/Terms |
Neoplasm Staging- Neoplasm Staging
- Staging, Neoplasm
- Tumor Staging
- Staging, Tumor
- Cancer Staging
- Staging, Cancer
TNM Staging- TNM Staging
- Staging, TNM
- TNM Staging System
- Staging System, TNM
- Staging Systems, TNM
- System, TNM Staging
- Systems, TNM Staging
- TNM Staging Systems
- TNM Classification
- Classification, TNM
- Classifications, TNM
- TNM Classifications
|
Below are MeSH descriptors whose meaning is more general than "Neoplasm Staging".
Below are MeSH descriptors whose meaning is more specific than "Neoplasm Staging".
This graph shows the total number of publications written about "Neoplasm Staging" by people in this website by year, and whether "Neoplasm Staging" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
Year | Major Topic | Minor Topic | Total |
---|
1995 | 0 | 10 | 10 | 1996 | 0 | 7 | 7 | 1997 | 0 | 10 | 10 | 1998 | 2 | 11 | 13 | 1999 | 0 | 7 | 7 | 2000 | 0 | 16 | 16 | 2001 | 2 | 14 | 16 | 2002 | 1 | 14 | 15 | 2003 | 1 | 11 | 12 | 2004 | 1 | 13 | 14 | 2005 | 5 | 22 | 27 | 2006 | 1 | 30 | 31 | 2007 | 0 | 27 | 27 | 2008 | 0 | 36 | 36 | 2009 | 1 | 28 | 29 | 2010 | 3 | 36 | 39 | 2011 | 2 | 34 | 36 | 2012 | 0 | 33 | 33 | 2013 | 4 | 45 | 49 | 2014 | 1 | 51 | 52 | 2015 | 2 | 55 | 57 | 2016 | 4 | 52 | 56 | 2017 | 1 | 78 | 79 | 2018 | 4 | 52 | 56 | 2019 | 2 | 54 | 56 | 2020 | 2 | 34 | 36 | 2021 | 0 | 25 | 25 | 2022 | 1 | 16 | 17 | 2023 | 0 | 17 | 17 | 2024 | 3 | 25 | 28 | 2025 | 0 | 9 | 9 |
To return to the timeline, click here.
Below are the most recent publications written about "Neoplasm Staging" by people in Profiles.
-
Simon LH, Saviers-Steiger C, Dunston ER, Galyean P, Kimball ER, Mendez J, Zickmund SL, Hansen PA, Ulrich CM, LaStayo PC, Steinberg D, Noren CS, Finch A, Seckinger L, Braun E, Chipman J, Brownson KE, Oza S, Coletta AM. Feasibility and acceptability of the Comprehensive Oncology Rehabilitation and Exercise (CORE) clinical workflow algorithm in patients with newly diagnosed stage I-III breast cancer who undergo surgery as first-line treatment. Cancer. 2025 May 01; 131(9):e35798.
-
Madan R, El Alam RH, Walker CM, Bang TJ, Bartel TB, Batra K, Brixey AG, Christensen JD, Cox CW, Gonzalez AV, Little BP, Lui NS, Maxfield H, Moore WH, Qin A, Shroff GS, Yasufuku K, Chung JH. ACR Appropriateness Criteria? Lung Cancer-Surveillance After Therapy. J Am Coll Radiol. 2025 May; 22(5S):S319-S342.
-
Leighl NB, Ismaila N, Durm G, Florez N, Freeman-Daily J, Pellini B, Mishra DR, Schenk EL, Sequist L, Singh N, Bazhenova L. Therapy for Stage IV Non-Small Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline, Version 2024.3. J Clin Oncol. 2025 04; 43(10):e17-e30.
-
von Itzstein MS, Burns TF, Dowell JE, Horn L, Camidge DR, York SJ, Eaton KD, Kyle K, Fattah F, Liu J, Mu-Mosley H, Gupta A, Nadeem U, Gao A, Zhang S, Gerber DE. Phase I/II Trial of Exportin 1 Inhibitor Selinexor plus Docetaxel in Previously Treated, Advanced KRAS-Mutant Non-Small Cell Lung Cancer. Clin Cancer Res. 2025 Feb 17; 31(4):639-648.
-
Woodard GA, Grau-Sepulveda M, Onaitis MW, Udelsman BV, David EA, Jacobs JP, Kosinski AS, Blasberg JD, Boffa DJ. Lobectomy vs Sublobar Resection in The Society of Thoracic Surgeons Database: Importance of Patient Factors and Lymph Node Evaluation. Ann Thorac Surg. 2025 May; 119(5):1071-1081.
-
Hunting JC, Price SN, Faucheux AT, Olson E, Elko CA, Quattlebaum A, Ruiz J, Lycan TW. Survival impact of immune-related adverse events in extensive stage small cell lung cancer patients: a retrospective cohort study. Immunotherapy. 2025 Jan; 17(1):19-24.
-
Antonoff MB, Mitchell KG, Kim SS, Salfity HV, Kotova S, Ripley RT, Neri AL, Sood P, Gandhi SG, Elamin YY, Donington JS, Jones DR, David EA, Swisher SG, Opitz I, Hayanga JWA, Rocco G. The Society of Thoracic Surgeons (STS) Clinical Practice Guideline on Surgical Management of Oligometastatic Non-small Cell Lung Cancer. Ann Thorac Surg. 2025 Mar; 119(3):495-508.
-
Northrop A, Christofferson A, Umashankar S, Melisko M, Castillo P, Brown T, Heditsian D, Brain S, Simmons C, Hieken T, Ruddy KJ, Mainor C, Afghahi A, Tevis S, Blaes A, Kang I, Asare A, Esserman L, Hershman DL, Basu A. Implementation and impact of an electronic patient reported outcomes system in a phase II multi-site adaptive platform clinical trial for early-stage breast cancer. J Am Med Inform Assoc. 2025 Jan 01; 32(1):172-180.
-
Mew A, Chau E, Bera K, Ramaiya N, Tirumani SH. Recommendations from Imaging, Oncology, and Radiology Organizations to Guide Management in Prostate Cancer: Summary of Current Recommendations. Radiol Imaging Cancer. 2025 Jan; 7(1):e240091.
-
Kolb JM, Davis C, Hochheimer CJ, Beilke S, Ma I, Fox C, Gallegos J, O'Hara J, Tarter W, Wani S. Time to Therapy May Not Impact Diagnosis Upstaging in Patients Referred for Management of Luminal Gastrointestinal Neoplasia. Dig Dis Sci. 2025 Feb; 70(2):786-793.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|